Nutraceutical International Corporation
(NASDAQ GS: NUTR)
Attention investors who purchased shares of Nutraceutical International Corporation before May 22, 2017:
Rigrodsky & Long is investigating potential claims against the board of directors of Nutraceutical International Corporation concerning possible breaches of fiduciary duty and other violations of law related to the Company’s agreement to be acquired by an affiliates of HGGC, LLC for $41.80 per share, or approximately $446 million.
Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Nutraceutical International Corporation (“Nutraceutical” or the “Company”) (NASDAQ GS: NUTR) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by an affiliate of HGGC, LLC (“HGGC”) in a transaction valued at approximately $446 million. Under the terms of the agreement, shareholders of Nutraceutical will receive $41.80 in cash for each share of Nutraceutical common stock.
If you own common stock of Nutraceutical and purchased any shares before May 22, 2017, if you would like to learn more about this investigation, or if you have any questions concerning this announcement or your rights or interests, please contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by telephone at (888) 969-4242, or by e-mail at email@example.com.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities fraud, shareholder corporate, and shareholder derivative litigation on behalf of shareholders in state and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a similar outcome.